TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

JACKSONVILLE, Florida, May 30, 2018 – TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that its President and CEO, Peter Hoang, will participate in a panel discussion and give a company presentation at the 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum, held June 1, 2018, at the Waldorf Astoria Chicago Hotel. Immuno-Oncology BD&L and Investment Forum TapImmune Company Presentation Date: Friday, June 1, 2018 Time: 12:20 PM CT Location: Track A Advances in Cell & Gene Therapies Panel Date: Friday, June 1, 2018 Time: 1:50 PM CT Location: Track A An audio webcast will be accessible via the News and Events section of the TapImmune website: https://www.markertherapeutics.com/events. An archive of the audio will remain available for 90 days following the presentation.[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer2]